FDA Sends Warning To Outset Medical Concerning Two Issues With Its Dialysis Device

The US Food and Drug Administration sent a warning letter to Outset Medical citing two concerns with the Tablo Hemodialysis System. Outset disclosed the letter in a recent filing with the US Securities and Exchange Commission.